Hepatic Low-Density Lipoprotein (LDL) Synthesis (Hepatic LDL Synthesis)

Hepatic LDL synthesis is the process by which the liver produces low-density lipoprotein (LDL) particles, a key component in cholesterol transport and metabolism. The liver packages cholesterol and triglycerides into VLDL, which is then converted to LDL in the bloodstream. This process is regulated by factors like SREBPs and the hepatic LDL receptor. Dysregulation of LDL synthesis contributes to hypercholesterolemia and cardiovascular disease, making it a key therapeutic target.

Other names

LDL Production in LiverHepatic Cholesterol MetabolismVLDL to LDL Conversion in Liver

Statins inhibit HMG-CoA reductase, reducing endogenous cholesterol synthesis and upregulating hepatic LDL receptor expression. Ezetimibe inhibits intestinal cholesterol absorption. Bempedoic Acid inhibits ATP citrate lyase. PCSK9 Inhibitors increase LDL receptor recycling.